Schneider, T. C., Wit, D. d., Links, T. P., Erp, N. P. v., Hoeven, J. J. M. v. d., Gelderblom, H., . . . Kapiteijn, E. Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial. Wiley.
Chicago Style (17th ed.) CitationSchneider, T. C., et al. Beneficial Effects of the MTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial. Wiley.
MLA (9th ed.) CitationSchneider, T. C., et al. Beneficial Effects of the MTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial. Wiley.
Warning: These citations may not always be 100% accurate.